10-Q Filing

TEVOGEN BIO HOLDINGS INC. CIK: 1860871 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001410578-21-000555`
Period End Date	20210930
Filing Date	20211217
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	lgstu-20210930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 21 Income Statement 14 Cash Flow Statement 11 Stockholders Equity 11

Balance Sheet 21 line items

Line Item	Tag	Value	Unit	Period
Deferred offering costs	`DeferredCosts`	$166.79K	USD	Point-in-time
Total other assets	`OtherAssets`	$166.79K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$166.79K	USD	Point-in-time
Preferred stock, par value, (per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$929.00	USD	Point-in-time
Accrued offering costs	`AccruedOfferingCosts`	$70.74K	USD	Point-in-time
Note payable - related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$81.53K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$153.20K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$153.20K	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Shares subject to forfeiture	`NumberOfSharesSubjectToForfeiture`	1.53M	shares	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Stock dividend ratio	`PreferredStockConvertibleConversionRatio`	0.02	pure	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.80K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.41K	USD	Point-in-time
TOTAL SHAREHOLDER'S EQUITY	`StockholdersEquity`	$18.02K	USD	Point-in-time
TOTAL SHAREHOLDER'S EQUITY	`StockholdersEquity`	$13.59K	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDER'S EQUITY	`LiabilitiesAndStockholdersEquity`	$166.79K	USD	Point-in-time

Income Statement 14 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$115.00	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.41K	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$11.41K	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$115.00	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-11.41K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-115.00	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-6.98K	USD	Point-in-time
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	10.32M	shares	1 Quarter
Weighted Average Number of Shares Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	10.32M	shares	2 Qtrs
Weighted Average Number of Shares Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.32M	shares	2 Qtrs
Basic net loss per common share	`EarningsPerShareBasic`	-	USD	2 Qtrs
Basic net loss per common share	`EarningsPerShareBasic`	-	USD	1 Quarter
Shares subject to forfeiture	`NumberOfSharesSubjectToForfeiture`	1.53M	shares	Point-in-time
Stock dividend ratio	`PreferredStockConvertibleConversionRatio`	0.02	pure	Point-in-time

Cash Flow Statement 11 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-11.41K	USD	2 Qtrs
General and administrative expenses paid by affiliate	`GeneralAndAdministrativeExpensesPaidByRelatedParties`	$10.48K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$929.00	USD	2 Qtrs
NET CHANGE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	-	USD	2 Qtrs
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Payment of deferred offering costs by note payable - related party	`PaymentOfDeferredOfferingCostsByNotePayableRelatedParty`	$71.05K	USD	2 Qtrs
Deferred offering costs included in accrued offering costs	`DeferredOfferingCostsIncludedInAccruedOfferingCosts`	$70.74K	USD	2 Qtrs
Payment of deferred offering costs by the Sponsor in exchange for the issuance of Class B ordinary shares	`DeferredOfferingCostsPaidInExchangeForIssuanceOfShares`	$25.00K	USD	2 Qtrs

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Shares subject to forfeiture	`NumberOfSharesSubjectToForfeiture`	1.53M	shares	Point-in-time
Stock dividend ratio	`PreferredStockConvertibleConversionRatio`	0.02	pure	Point-in-time
Balance at the beginning	`StockholdersEquity`	$18.02K	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$13.59K	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$380.00K	USD	2 Qtrs
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-11.41K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-115.00	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.98K	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$18.02K	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$13.59K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.